David M. Suchanek, RPh

A retailer's decision to get involved in the specialty pharmacy marketplace should be an informed one that encompasses careful research and a full understanding of all of the stakeholder requirements.

The procedures and services involved in specialty pharmacy are different from the community model.

The growth of this field is dependent upon connecting stakeholders in a productive way.

Pharmacists who want to enter specialty pharmacy can mitigate the risks by educating themselves on the market.

Is a low-molecular-weight heparin program right for your pharmacy?

The robust market and pipeline for multiple sclerosis treatment means patients and pharmacists, have more options than ever.

The interpretation of Fair Market Value is not so black and white. Here's how a pharmacy or pharmaceutical manufacturer can put policies on place to bring clarity.

The management of type 1 and type 2 diabetes is a booming area of research and development, and the pipeline contains many innovative drugs and dosage forms.